論文

査読有り 国際誌
2018年12月25日

Accurate diagnosis of mismatch repair deficiency in colorectal cancer using high-quality DNA samples from cultured stem cells.

Oncotarget
  • Tadayoshi Yamaura
  • Hiroyuki Miyoshi
  • Hisatsugu Maekawa
  • Tomonori Morimoto
  • Takehito Yamamoto
  • Fumihiko Kakizaki
  • Koichiro Higasa
  • Kenji Kawada
  • Fumihiko Matsuda
  • Yoshiharu Sakai
  • M Mark Taketo
  • 全て表示

9
101
開始ページ
37534
終了ページ
37548
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.18632/oncotarget.26495

Mismatch repair (MMR)-deficient or microsatellite instability (MSI) colorectal cancer includes two subtypes; Lynch syndrome and sporadic MSI cancer, both of which generate multiple neoantigens due to unrepaired mutations. Although such patients respond very well to immune checkpoint therapy, their diagnosis can be confused by low quality DNA samples owing to formalin fixation and/or low cancer cell content. Here we prepared high-quality DNA samples from in vitro-cultured cancer spheroids that consisted of the pure cell population. We evaluated their diagnostic power by on-chip electrophoresis, mutational burden assessment, and direct sequencing. Because formalin-fixed paraffin-embedded (FFPE) tissues are widely used as the DNA source, we compared such samples with spheroid DNA. Additionally, we performed immunohistochemistry (IHC) for MMR proteins on spheroids as well as primary tumor sections. Of 111 cases of colorectal cancer patients, we found seven MSI-high cases in which all diagnostic results agreed on spheroid-based assays, whereas the results with the FFPE DNA were less reliable though analyzable. Importantly, there was an MSS case that appeared as MSI by IHC on primary tumor sections. Based on these results, we propose to employ cultured cancer spheroids as the source of both DNA and IHC specimens for more reliable clinical diagnosis.

リンク情報
DOI
https://doi.org/10.18632/oncotarget.26495
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/30680068
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331025
ID情報
  • DOI : 10.18632/oncotarget.26495
  • PubMed ID : 30680068
  • PubMed Central 記事ID : PMC6331025

エクスポート
BibTeX RIS